AppliedXL Partners with Bloomberg to Integrate Real-Time Biotech Intelligence

Key Takeaways

• Bloomberg Terminal users gain direct access to AppliedXL's event detection technology
• System processes 7,000+ daily updates, filtering to 60-80 curated stories
• Coverage extends to 14,000 public and private companies globally
• Human-in-the-loop methodology ensures contextually accurate alerts

AppliedXL has entered into a collaboration with Bloomberg to provide a new stream of real-time clinical data for the life sciences sector. Effective immediately, Bloomberg Terminal users have access to AppliedXL's AI-generated coverage of clinical trials, designed to identify catalyst events in the pharmaceutical industry as they develop.

Data Processing and Signal Detection

The global clinical trial ecosystem produces approximately 7,000 individual updates daily across various registries and regulatory databases. Managing this volume of information presents a significant resource challenge for investors and corporate decision-makers.

AppliedXL's infrastructure addresses this by filtering high-volume data streams to isolate material updates.

The system ingests these 7,000+ daily updates, utilizing proprietary algorithms to remove administrative changes. The output is a curated feed of approximately 60-80 news stories per day. By monitoring irregularities across nearly 100 categories of trials, the system detects specific operational shifts, such as enrollment deviations or timeline delays, that may indicate broader corporate developments.

Scope of Coverage

This integration provides Bloomberg Terminal users with direct access to AppliedXL's event detection technology, characterized by the following metrics:

• Company Coverage: Monitoring extends to 14,000 public and private companies, encompassing both domestic and international entities

• Curated Reporting: The system filters raw registry data to produce a streamlined feed of significant trial events

• Pattern Recognition: AI models analyze historical data to interpret real-time irregularities, providing context on trial status changes

• Verification: The technology incorporates an automated fact-checking process, which is audited by domain experts and journalists to maintain data accuracy

Hybrid AI Methodology

"There's no artificial intelligence without human wisdom," stated Francesco Marconi, Co-Founder & CEO of AppliedXL. "We use machines to understand the patterns in data, but we need humans to understand the contexts that influence them."

This "human-in-the-loop" approach is designed to ensure that the alerts delivered to Bloomberg Terminal users are vetted and contextually accurate, supporting proactive decision-making and risk monitoring.